Citigroup’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,427
| Closed | -$3.8K | – | 4771 |
|
|
2024
Q4 | $3.8K | Buy |
6,427
+402
| +7% | +$238 | ﹤0.01% | 4630 |
|
|
2024
Q3 | $10.6K | Sell |
6,025
-217
| -3% | -$382 | ﹤0.01% | 4482 |
|
|
2024
Q2 | $8.55K | Sell |
6,242
-2,132
| -25% | -$2.92K | ﹤0.01% | 4431 |
|
|
2024
Q1 | $28.8K | Buy |
8,374
+1,809
| +28% | +$6.22K | ﹤0.01% | 4164 |
|
|
2023
Q4 | $16.1K | Buy |
6,565
+5,947
| +962% | +$14.6K | ﹤0.01% | 4301 |
|
|
2023
Q3 | $1.05K | Sell |
618
-13,361
| -96% | -$22.7K | ﹤0.01% | 4329 |
|
|
2023
Q2 | $41.9K | Buy |
13,979
+13,452
| +2,553% | +$40.4K | ﹤0.01% | 4055 |
|
|
2023
Q1 | $1.41K | Sell |
527
-40,349
| -99% | -$108K | ﹤0.01% | 4406 |
|
|
2022
Q4 | $337K | Buy |
40,876
+38,488
| +1,612% | +$318K | ﹤0.01% | 2762 |
|
|
2022
Q3 | $18K | Buy |
2,388
+930
| +64% | +$7.01K | ﹤0.01% | 4053 |
|
|
2022
Q2 | $4K | Sell |
1,458
-2,717
| -65% | -$7.45K | ﹤0.01% | 4881 |
|
|
2022
Q1 | $21K | Sell |
4,175
-66,419
| -94% | -$334K | ﹤0.01% | 4372 |
|
|
2021
Q4 | $1.39M | Buy |
70,594
+43,694
| +162% | +$858K | ﹤0.01% | 2254 |
|
|
2021
Q3 | $792K | Sell |
26,900
-13,071
| -33% | -$385K | ﹤0.01% | 2564 |
|
|
2021
Q2 | $1.69M | Buy |
39,971
+38,865
| +3,514% | +$1.65M | ﹤0.01% | 2212 |
|
|
2021
Q1 | $56K | Buy |
1,106
+925
| +511% | +$46.8K | ﹤0.01% | 3982 |
|
|
2020
Q4 | $6K | Buy |
+181
| New | +$6K | ﹤0.01% | 4972 |
|